• Home
  • Company Information
  • Biofil Chemicals & Pharmaceuticals Ltd
B

Biofil Chemicals & Pharmaceuticals Ltd Share Price Pharmaceuticals
₹ 36.92 +5.40 (17.13%)

  • NSE
  • BSE

What is Biofil Chemicals & Pharmaceuticals Ltd revenue and profit growth?

  • BSE Code 524396
  • NSE Symbol BIOFILCHEM
  • ISIN Demat INE829A01014
  • Book Value (₹) 13.09
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 53.71
  • P/E (TTM) 19.42
  • EPS (TTM) 1.70
  • Div Yield (%) 0.00

Is Biofil Chemicals & Pharmaceuticals Ltd financially strong enough to invest in?

Today’s Low 31.22
Today’s High 37.82

36.92
52W Low 25.60
52W High 57.19

36.92
Open 31.22
Prev. Close 31.52
Volume 7,865.00

What corporate actions has Biofil Chemicals & Pharmaceuticals Ltd announced recently?

Biofil Chemicals & Pharmaceuticals Limited - Shareholders meeting
Sep 29, 2025

Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2025

Biofil Chemicals & Pharmaceuticals Limited - General Updates
Sep 29, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Scruitinizer report and voting result in pdf form.

Biofil Chemicals & Pharmaceuticals Limited - Change in Management
Sep 29, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about following events for which disclosure as required under Regulation 30 read with sub-clause 7 of Para A of Part A of Schedule III:1.Confirmation of appointment of Joshi Sahay and Company, Practicing Company Secretary (Unique Code: P2025MP322400 and Peer Review Certificate No.: 6873/2025) as Secretarial Auditor of the Company and fix their remuneration - attached as Annexure-I.2.Confirmation of re-appointment of Mr. Ashok Kumar Ramawat (DIN: 08818263) as Independent Director, for a second term of 5 years commencing from 25th August, 2025 to 24th August, 2030, - attached as Annexure-II. 3.Confirmation of re-appointment of Mr. Satish Beohar (DIN: 09220291) as Independent Director, for a second term of 5 years commencing from 30th June, 2026 to 29th June, 2031, - attached as Annexure-II.4.Confirmation for Change in designation of Mr. Ketan Shah (DIN: 08818212) from Whole Time Director to Chairman and Managing Director - attached as Annexure-III5.Confirmation of appointment of Mr. Smitesh Shah (DIN: 00326182) as a Promoter Non Executive Non-Independent Director of the Company - attached as Annexure-IV.

Biofil Chemicals & Pharmaceuticals Limited - Trading Window
Sep 29, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Biofil Chemicals & Pharmaceuticals Limited - Change in Company Secretary/Compliance Officer
Apr 19, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

Biofil Chemicals & Pharmaceuticals Limited - Change in Management
Apr 19, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about change in Management

Biofil Chemicals & Pharmaceuticals Limited - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Apr 19, 2025

BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

Biofil Chemicals & Pharmaceuticals Limited - Disclosure of material issue
Apr 19, 2025

Biofil Chemicals & Pharmaceuticals Limited has informed regarding Disclosure of material issue

What is the history and background of Biofil Chemicals & Pharmaceuticals Ltd?

Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole, cefaclor, pentazocine, cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments. During the year 1999-2000, the company had achieved a turnover of Rs.1164.03 lakhs.
Founded: 1985
Chairman: Ketan Shah
Managing Director: Ketan Shah
Address: 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015,

Frequently Asked Questions

What is the share price of Biofil Chemicals & Pharmaceuticals Ltd today? +
How do I buy Biofil Chemicals & Pharmaceuticals Ltd shares? +
What is Biofil Chemicals & Pharmaceuticals Ltd's market cap? +
What is the 52-week high and low of Biofil Chemicals & Pharmaceuticals Ltd? +
What is the PE ratio of Biofil Chemicals & Pharmaceuticals Ltd? +
Does Biofil Chemicals & Pharmaceuticals Ltd pay dividends? +
Close Language Tab
Locate us
Languages
Downloads